Drug
Epoprostenol
Epoprostenol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_4
2
40%
Ph phase_2
1
20%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 42 (50.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
NCT01470144
completedphase_2
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
NCT02251041
completed
Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
NCT01387191
completedphase_4
Epoprostenol in Pulmonary Embolism
NCT01014156
completedphase_4
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
NCT00004754
Clinical Trials (5)
Showing 5 of 5 trials
NCT01470144Phase 3
Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
NCT02251041Phase 2
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
NCT01387191
Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
NCT01014156Phase 4
Epoprostenol in Pulmonary Embolism
NCT00004754Phase 4
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5